秦皮素对大肠埃希菌作用机制的初步研究

目的以大肠埃希菌ATCC 25922为供试菌,探讨秦皮素的抑菌活性及其作用机制。方法利用TTC法测定秦皮素对大肠埃希菌ATCC 25922的最低抑菌浓度;通过测定加药前后菌体培养液电导率和大分子的变化及观察扫描电镜和透射电镜电镜结果,分析秦皮素对其细胞膜的影响;通过SDS-PAGE测定秦皮素对供试菌株蛋白含量的影响;采用逐个检出法研究秦皮素对大肠埃希菌ATCC 25922质粒合成的抑制作用。结果秦皮素可抑制大肠埃希菌ATCC 25922的生长,其最低抑菌浓度为40μg/mL。秦皮素作用菌体5 h后,培养液中的电导率比对照组增加1.96%,但DNA和RNA大分子增加的不明显。秦皮素作用大肠埃希菌20 h后,菌体可溶性蛋白总量比对照组降低42%。秦皮素对大肠埃希菌的质粒有消除作用,药物作用48 h后,秦皮素对大肠埃希菌的质粒消除率为60.3%。结论秦皮素可抑制大肠埃希菌的生长,其抑菌作用机制与抑制菌体内蛋白质合成和消除菌体内的质粒有关,但对大肠埃希菌细胞膜的影响不大。     

Antihyperglycemic effect of fraxetin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats

Epidemiological studies have demonstrated that the diabetes mellitus is a serious health burden for both governments and healthcare providers. The present study was hypothesized to evaluate the antihyperglycemic potential of fraxetin by determining the activities of key enzymes of carbohydrate metabolism in streptozotocin (STZ) – induced diabetic rats. Diabetes was induced in male albino Wistar rats by intraperitoneal administration of STZ (40 mg/kg b.w). Fraxetin was administered to diabetic rats intra gastrically at 20, 40, 80 mg/kg b.w for 30 days. The dose 80 mg/kg b.w, significantly reduced the levels of blood glucose and glycosylated hemoglobin (HbA1c) and increased plasma insulin level. The altered activities of the key enzymes of carbohydrate metabolism such as glucokinase, glucose-6-phosphate dehydrogenase, glucose-6-phosphatase, fructose-1,6-bisphosphatase and hepatic enzymes (aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP)) in the liver tissues of diabetic rats were significantly reverted to near normal levels by the administration of fraxetin. Further, fraxetin administration to diabetic rats improved body weight and hepatic glycogen content demonstrated its antihyperglycemic potential. The present findings suggest that fraxetin may be useful in the treatment of diabetes even though clinical studies to evaluate this possibility may be warranted.